Summary Cytogenetic findings of our 30 previously reported and eight new patients with malignant pleural mesothelioma were summarised and correlated with asbestos fibre burden in lung tissue and survival. Successful cytogenetic analyses were performed on cells obtained from the tumours and/or pleural effusions of 34 of the 38 patients. Clonal chromosomal abnormalities were detected in 25 patients, 19 of them studied before treatment. Nine patients, seven of them studied before treatment, had normal karyotypes and/or non-clonal chromosomal abnormalities. Most of the karyotypic findings in the patients with clonal abnormalities were complex and heterogeneous, and no chromosome aberration specific to mesothelioma could be demonstrated. The following numerical abnormalities in decreasing order of frequency were preferentially present in karyotypic changes: -22, + 7, -1, -3, -9, + 11 and -14 (-/ + denoting partial or total loss or gain). Translocations and deletions involving a breakpoint at Ipl -p22 were the most frequent structural aberrations. Statistically significant correlations were found between high content of asbestos fibres in lung tissue and partial or total losses of chromosomes 1 and 4, and a breakpoint at lplI-p22 (P = 0.0001, P = 0.003, P = 0.009, respectively). The number of copies of chromosome 7 short arms was inversely correlated with survival (P = 0.02). In this study no diagnostic cytogenetic markers of mesothelioma were found, instead the copy number of chromosome 7 short arms turned out to be a possible prognostic factor in malignant mesothelioma.
The incidence of malignant mesothelioma has risen with the increased use of asbestos in industry (Antman, 1980; Browne, 1986) . Mesothelioma is characterised by a long latency period, diagnosis at an advanced stage, resistance to therapy, and short survival (Antman, 1980) . The histological, and especially cytological, distinction between mesothelioma and adenocarcinoma metastatic to the pleura can be difficult (Battifora & Kopinski, 1985; Burns et al., 1985) . Specific chromosomal abnormalities serve as diagnostic markers and/ or prognostic factors in several malignancies (Heim & Mitelman, 1987) . Reports on cytogenetic analyses of mesothelioma have been sparse and no anomaly specific to mesothelioma has been found so far (Ayraud, 1975; Mark, 1978; Wake et al., 1981; Gibas et al., 1986; Stenman et al., 1986; Bello et al., 1987; Popescu et al., 1988; Tiainen et al., 1988; . In this report a summary of the chromosomal analyses of our 30 previously reported (Tiainen et al., 1988) and eight new malignant pleural mesotheliomas is presented, and the cytogenetic findings are evaluated for their correlations with concentrations of asbestos fibres in lung tissue and survival.
Materials and methods
Clinical material Seventy-five specimens from tumours and/or pleural effusions from 38 patients with malignant pleural mesothelioma diagnosed in the catchment area of the Helsinki University Central Hospital between 1984 and were cytogenetically studied. The cytogenetic data and patient characteristics of patients nos 1-30 have been previously reported (Tiainen et al., 1988) . The diagnosis and histological subtyping of mesothelioma were confirmed by two different pathology panels, by both the Finnish National Mesothelioma Pathology Panel and the corresponding panel of the Lung Cancer Cooperative Group of the European Organisation for Research and Treatment of Cancer. All available methods to exclude other primaries were applied (Corson, 1987) . Thirty of the patients were male, and the median age at diagnosis was 59 (range 39-83) years. The histological subtype was epithelial in 19 patients, mixed in 16, and fibromatous in 2. In one patient material for cytological diagnosis only was available not allowing subtyping. Most (25) of the patients had clinical stage II A disease.
Asbestos exposure was evaluated in 16 patients by determination of the content of asbestos fibres in samples of dried lung tissue. Eleven patients had more than 5 million asbestos fibres per gram in their lung tissue (range 5.5-370 million fibres per gram dry tissue; Table I ). They had been exposed to asbestos in shipyards, construction and maintenance work. Five patients had less than 5 million fibres per gram in lung tissue (range 0.1 -3.1 million fibres per gram dry tissue; Table  I ). They had been exposed in various occupations in construction industry, electrical installations, powerplant and transport trades. The main fibre types found in both groups were crocidolite, amosite and anthophyllite asbestos. The latency period between the exposure and the diagnosis of mesothelioma was more than 20 years and the work where the exposure was considered to have taken place had continued for typically several years (Tuomi et al., 1989) .
The patients were treated with multimodality therapy consisting of debulking surgery, chemotherapy and hemithorax irradiation. Chemotherapy comprised either single agent mitoxantrone, single agent epirubicin or combination chemotherapy with cyclophosphamide, vincristin, doxorubicin and dakarbazin (CYVADIC). Three different time-dose-fractionation programmes of hemithorax irradiation were applied (Holsti & Mattson, 1988; Mattson et al., 1989) . More detailed patient characteristics, individual therapies and survival data are presented in Table I . if required, the C-and R-banding techniques also. Chromosomal abnormalities were considered as clonal if they appeared in at least two cells, except chromosomal losses, which had to be in at least three cells. The constitutional karyotype of every patient was confirmed as being normal by cytogenetic analysis of cells from peripheral blood.
Statistical analyses
Statistical analyses were performed with the BMDP statistical software package (Dixon, 1985) . Differences between groups were analysed with the likelihood ratio X2 test or analysis of variance. Survival analyses were calculated by the product limit method, and the groups were compared by the Mantel -Cox test.
Results
Success rates in cytogenetic analyses of different specimens Metaphases for karyotypic analyses were obtained from 56 of the 75 specimens, 32 of 38 (84%) specimens from pleural effusions and 24 of 37 (65%) specimens from tumours. Thirty-seven per cent of the specimens from pleural effusions yielded metaphases with clonal chromosomal abnormalities and 47% yielded metaphases with normal karyotypes and/or non-clonal abnormalities. The corresponding figures for specimens from tumours were 51% and 14% respectively.
Cytogenetic findings in samples of 34 patients Successful chromosomal studies were performed on specimens from 34 patients. Clonal major karyotype abnormalities and/or simple karyotype abnormalities were detected in tumour cells from 25 patients (Table I, 19 of them before treatment). In most of the patients there were also cells with normal karyotype and cells with nonclonal abnormalities in the same specimen. In two patients only a few normal metaphases were found (Table I , both before treatment). The remaining seven patients had a mixture of normal and nonclonal metaphases (Table I , five before treatment). Detailed results of the chromosomal analyses of patients nos 1-30 have been previously reported (Tiainen et al., 1988) . The karyotypic findings in the samples of patients nos 31-38 (all before treatment) and in a new specimen (metastasis, after treatment) of patient no. 20 are presented in Table II. A stemline with a pseudodiploid or near diploid chromosome number was detected in 21 of the patients with clonal abnormalities. Thirteen of them also had polyploid forms of der(l l)t(X;l l)(ql3;p13) 13 ?del (22) 3,4,9,9,10, 10,13,13,14, 15,17,18,19 * 1,1,3,4,4, 5,6,6,8,8, 9,9,10,10, 13,13,14,14, 15,15,16,16, 17,17,18 41 -47 Figure 2 ). Clonal numerical chromosome changes including partial or total chromosomal gains and losses are summarised in Figure 3 . Distribution of breakpoints of the clonal structural changes on different chromosomes is demonstrated in Figure 4 . 11, 11, 10 and 9 patients respectively. Partial or total polysomy 7 was the most frequent chromosomal gain in the tumour cells of the 25 patients, it was detected in 13 patients (52%). Partial polysomy appeared especially in the form of extra copies of the short arm of chromosome 7 (isochromosomes of 7p were detected in three patients and an additional translocation chromosome involving 7p material in one patient). Gain of chromosome 11 was seen in 11 patients, gain of chromosome 5 in eight patients (two of them having isochromosomes (5p)) and gain of chromosome 12 in seven patients. The involvement of the above abnormalities in the karyotypic changes in the 25 mesotheliomas is presented in Table III .
Most breakpoints occurred in chromosomes 1, 3, 2, 9, 11 and 7, in decreasing order of frequency (Figure 4 ). Breakage in chromosomal bands plp, lpll3, lp22, lq21, 3pl3, 3p2l, 6ql2, 7ql 1.2, 21q22 and 22ql 1.2 occurred in more than two patients. There was a cluster of breakpoints in regions lpl 1-p22 (10 patients, Table III), lql2-q25 (8 patients), 3pl 1-21 (6 patients) and 7ql 1.2 (4 patients).
The co-existence of different chromosomal abnormalities The correlations between the different chromosomal alterations are demonstrated in Figure 5 . Two groups can be separated: a group of chromosomal gains accompanying partial or total polysomy 7, and a group of chromosomal losses accompanying partial or total loss of chromosome 3 or a breakpoint at lpl -p22. In the first group partial or total polysomy 7 tended to occur together with polysomies 5, 11 and 12 (for each, P<0.01). Six of the seven cases that had polysomy 12 had also gained chromosome 11 (P <0.001). In the second group, the most statistically significant correlations (P<0.0001) were detected between a breakpoint at lpl I -p22 and -14; lpl I -p22 and -15; -1 and -4; -1 and -9; -3 and del(3p); -3 and -9; -3 and -22; and between -4 and -9 (-denoting partial or total loss (Table I) , and the presence of each chromosomal abnormality presented in Table III . As partial poly- , 3, 5, 6, 8, 9, 10, 12, 13, 14, 16, 17, 18, 21, 23, 25, 26, 27 and 29 (Tiainen et al., 1988) ) and each dot and each dotted line (patients nos 20, 31, 32, 33, 35 and 36) represent one breakpoint (lines indicate breakpoints that could not be determined exactly).
-1%.%*'~-15 P < 0.01, negative correlation P < 0.01, positive correlation P < 0.001, positive correlation P < 0.0001, positive correlation Figure 5 Co-existence of different chromosome abnormalities.
-/ +, partial or total chromosome loss or gain; del3p, deletion of the p-arm of chromosome 3; bplpl -p22, breakpoint at Ipl I -p22.
somy 7 appeared especially in the form of extra copies of the p-arms, the significance of polysomy 7 was evaluated by the number of additional copies of 7p. Partial or total losses of chromosomes 1 and 4, and chromosomal rearrangements involving a breakpoint at lpll-p22 were consistently accompanied by asbestos fibre concentrations greater than 5 million fibres per gram of dried lung tissue (P = 0.0001, P = 0.003 and P = 0.009 respectively, Figure lb ). In addition, the number of copies of chromosome 7 short arms in the tumour cells correlated inversely with survival (P = 0.02). Patients with monosomy 7p or with a normal copy number of 7p:s survived longer than those with 1-4 additional 7p:s, and the more copies of chromosome 7 p-arms that were present in the tumour cells the worse was the prognosis (Figure 6 ). Months after diagnosis Figure 6 Correlation between the number of copies of chromosome 7 p-arms and survival (P = 0.02 1, 2, 4, 5, 11, 12, 15, 19, 20, 22, 24, 25, 27, 31, 34, 35, 36 and 38); and f, loss of a copy of 7p (patients nos 3, 13 and 32).
Discussion
In the present study the cytogenetic data were obtained mainly from specimens from the primary tumours received before treatment of 34 patients with malignant pleural mesothelioma. The histological diagnosis and subtyping were based on the same specimens. (abnormal clones in 26 cases) consistent involvement of chromosomes 1, 3, 6, 9 and 13 in structural changes and chromosomes 4 and 22 in losses and chromosomes 5, 7 and 20 in gains was found. Our analysis of the co-existence of different chromosome abnormalities showed that two groups could be separated: chromosome 5, 7, 11 and 12 gains in the first group, and chromosome 1, 3, 4, 9, 14, 15 and 22 losses and a breakpoint at lpll-p22 in the second. Such correlations at the chromosomal level may reflect correlations at the molecular level: co-operation of different oncogenes or growth factor genes, loss of suppressor genes, gene dosage effect or gene position effect. It is interesting that NRAS and two NRAS-like oncogenes are located in chromosomal regions frequently involved in chromosomal changes in mesotheliomas: Ip13 and/or lp22, 9p and 22 (Human Gene Mapping 9.5, 1988) . The possible role of NRAS in mesothelioma is not yet known. Several oncogenes, like ERBB (EGFR), which has been shown to be amplified in some tumours (Hollstein et at., 1988) , and the multiple drug resistance gene (P-glycoprotein gene), the overexpression of which has been detected in drug resistant cell lines (Lemontt et al., 1988) , are located on chromosome 7 (Human Gene Mapping 9.5, 1988). Elevation of platelet-derived growth factor (PDGF) A-and B-chain expression has been detected in human mesothelioma cell lines (Gerwin et al., 1987; Versnel et al., 1988b) . The PDGF A-chain gene is located on chromosome 7 (Bonthron et al., 1988 ) and the PDGF B-chain gene is on chromosome 22 (Human Gene Mapping 9.5, 1988) . The PDGF B-chain receptor has also been shown to be overexpressed in mesothelioma cell lines suggesting possible autocrine growth of mesothelioma cells by this growth factor (Versnel et al., 1988a) . The PDGF receptor has been mapped to chromosome 5 (Human Gene Mapping 9.5, 1988).
The various chromosomal abnormalities in our study and their complex relations may reflect the fact that the tumours were diagnosed and studied at an advanced stage of their evolution. The primary chromosomal abnormalities could have become masked by several secondary changes related to tumour progression or ageing. However, three patients in this study had quite simple karyotypic changes: patient no. 16: 48,XX, + 5,+ 7; patient no. 31: 46,XY,t(9; 1 1)/+21,t(14 g;17 g)/ t(5; 13) (three different clones); and patient no. 36: 50,XY, + X, + Y, + i(5p), + i(5p). Patients nos 6 and 8 also had simple clones (45,XY,-Y and 47,XY,+Y respectively) in specimens obtained before treatment from their tumours, but quite different clones involving complex chromosomal abnormalities in other specimens obtained also before treatment from the same tumours. It may be possible that in patients nos 16, 31 and 36, as well as in the patients with normal karyotypes and/or nonclonal abnormalities, complicated clones were also present but not detected by our current cytogenetic analysis.
Distinguishing mesothelioma from carcinoma metastatic to the pleura remains a major problem since there is no specific stain or test to identify mesothelioma cells and only few carcinomas have intracellular mucin that is diagnostic to adenocarcinoma. Several recently described monoclonal antibodies may facilitate accurate diagnosis (Lee et al., 1986; Anderson et al., 1987) .
The consistent chromosomal abnormalities in mesothelioma shown in this and in other studies do not, at present, have diagnositic value. Several other solid tumours share similar patterns of chromosomal alterations. In a study of 48 different specimens from solid tumours of 10 different tissues, especially duplication of chromosome 7 and structural abnormalities involving chromosomes 1, 3, 7 and 11 were preferentially present in the karyotypic changes (Teyssier, 1987) . The same abnormalities are also described in adenocarcinoma of the lung Fan & Li, 1987) the pleural metastases of which may be difficult to distinguish histologically and cytologically from mesothelioma. Breakpoints at 1p12-p22 are frequently seen in malignant melanoma (Balaban et al., 1986) , 1982) and renal cell carcinomas (Kovacs et al., 1987) . Extra copies of chromosome 7 are frequent in malignant melanoma (Balaban et al., 1986) , bladder cancer (Sandberg, 1986 ) and malignant glioma (Bigner et al., 1988) .
Monosomy 22 is characteristic to meningioma (Zang, 1982) .
Some of the consistent chromosomal abnormalities in mesothelioma in our study showed a correlation with the asbestos fibre burden of the corresponding lung. Partial or total losses of chromosomes I and 4, and translocations and deletions involving a breakpoint at IpI -p22 correlated with high content of asbestos fibres in lung tissue. In asbestosinduced rat mesotheliomas (Libbus & Craighead, 1988) and in Syrian hamster cell lines transformed by asbestos (Oshimura et al., 1986) non-random karyotypic changes have been described. It is not yet demonstrated that asbestos induces specific chromosome changes in human mesothelial cells. So far we are aware of only one report of chromosomal defects in human mesothelial cells exposed to asbestos (Lechner et al., 1985) . Losses of chromosomes 11 and 21, dicentric chromosomes, double minute chromosomes and other markers were described. It is possible that asbestos fibres cause chromosomal abnormalities at random sites but that cells with chromosomal rearrangements in the region lpll-p22 or losses of chromosomes 1 or 4 have a selective advantage in tumour progression. The possible relation between the NRAS oncogene located in lpl3 and/or lp22 and exposure to asbestos remains unknown. It is also noteworthy that the lpll -p22 region contains several fragile sites (Human Gene Mapping 9.5, 1988) where breakage could be induced more easily.
There was a statistically significant correlation between the number of copies of chromosome 7 p-arms and the prognosis. The more copies of 7p:s that were present in the tumour cells the shorter was survival. Results of the different multimodality treatment programs used in our patient series have been reported elsewhere (Holsti & Mattson, 1988) . None of the therapies was efficient, and there was no significant difference between the groups. Trisomy 7 (or i(5p)) has been suggested to be associated with increased aggressiveness of a tumour in bladder cancer (Sandberg, 1986) . Additionally, extra copies of chromosome 7 p-arms have been described in advanced malignant melanomas (Balaban et al., 1986) . Chromosome 7 includes several protooncogenes and growth factor genes the amplification of which could affect the tumour's behaviour.
In this study no diagnostic marker of mesothelioma was identified by our cytogenetic analysis. Instead, correlations between chromosome abnormalities, asbestos exposure and survival were demonstrated. Further studies are, however, needed to confirm whether the copy number of chromosome 7 short arms can be considered a prognostic factor in mesothelioma. When more cytogenetic and molecular genetic data about mesothelioma accumulate mesothelioma-specific genetic alterations may be detected and new clinical correlations will be identified.
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